Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med. 2006 Dec; 119(12):1062-72.